Joshua A. Weiner - Publications

Drawing a line in the sand: impact of analytical choices on anti-drug antibody cut-points and testing outcomes.

Journal: Bioanalysis

Published: July 14, 2026

Second Report of the American Intestinal Transplant Working Group: New Insights Into Risk Factors, Treatment Regimens, and Outcomes of Malignancy After Intestinal Transplantation.

Journal: Transplantation

Published: June 19, 2026

IgA binding characteristics of golden hamster and ferret Fcα receptors.

Journal: Journal of immunology (Baltimore, Md. : 1950)

Published: May 09, 2026

Intranasal Replicating Adenovirus type 4-SARS-CoV-2 Recombinants Induce Superior Immune Response Durability and Efficacy in Preclinical Testing Compared to Standard Intramuscular Vaccines.

Journal: bioRxiv : the preprint server for biology

Published: April 29, 2026

Trending ileal microbiome dysbiosis over time as an early assessment of intestinal transplant rejection risk.

Journal: American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons

Published: April 06, 2026

Time to HIV rebound after antiretroviral therapy interruption: a double-blind randomised placebo-controlled trial of long-acting broadly neutralising antibodies; The RIO Trial.

Journal: medRxiv : the preprint server for health sciences

Published: February 12, 2026

Effect of inactivated poliovirus vaccine on nasal mucosal immunity and pharyngeal shedding following novel oral poliovirus vaccine type 2 challenge: A randomized, open-label trial.

Journal: The Journal of infectious diseases

Published: February 09, 2026

Time to HIV rebound after infusion of long-acting broadly neutralising antibodies 3BNC117-LS and 10-1074-LS and analytical treatment interruption (the RIO trial): a double-blind, randomised, placebo-controlled trial.

Journal: The lancet. HIV

Published: December 09, 2025

IgG binding characteristics of ferret Fcγ receptors.

Journal: mAbs

Published: November 18, 2025

Bispecific 10E8.4/iMab broadly neutralizing antibody in people with or without HIV-1: a partially randomized phase 1 trial.

Journal: Nature medicine

Published: October 29, 2025

Predicting Post-intestinal Transplant Patient Survival Based on A Priori Data.

Journal: Transplantation

Published: October 13, 2025

Major Histocompatibility Complex Class I Matching is Necessary but not Sufficient for Tolerance Induction to Vascularized Composite Allografts After Donor Hematopoietic Cell Transplantation.

Journal: Transplantation direct

Published: October 10, 2025